Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma

A Barsouk, JS Aluru, P Rawla, K Saginala, A Barsouk - Medical Sciences, 2023 - mdpi.com
Head and neck squamous cell carcinoma (HNSCC) is a group of malignancies, involving
the oral cavity, pharynx, hypopharynx, larynx, nasal cavity, and salivary glands, that together …

Cervical cancer prevention and control in women living with human immunodeficiency virus

PE Castle, MH Einstein… - CA: a cancer journal for …, 2021 - Wiley Online Library
Despite being highly preventable, cervical cancer is the fourth most common cancer and
cause of cancer death in women globally. In low‐income countries, cervical cancer is often …

Real-world effectiveness of human papillomavirus vaccination against cervical cancer

SK Kjaer, C Dehlendorff, F Belmonte… - JNCI: Journal of the …, 2021 - academic.oup.com
Background The primary goal of human papillomavirus (HPV) vaccination is to reduce
morbidity and mortality from HPV-associated disease, especially cervical cancer. We …

Carcinogenic human papillomavirus infection

M Schiffman, J Doorbar, N Wentzensen… - Nature reviews Disease …, 2016 - nature.com
Infections with human papillomavirus (HPV) are common and transmitted by direct contact.
Although the great majority of infections resolve within 2 years, 13 phylogenetically related …

[HTML][HTML] A review of HPV-related head and neck cancer

K Kobayashi, K Hisamatsu, N Suzui, A Hara… - Journal of clinical …, 2018 - mdpi.com
Head and neck squamous cell carcinomas (HNSCCs) arise in the mucosal lining of the
upper aerodigestive tract. Tobacco and alcohol use have been reported to be associated …

[HTML][HTML] HPV vaccines–a review of the first decade

DM Harper, LR DeMars - Gynecologic oncology, 2017 - Elsevier
Abstract Pre-adolescent girls (9–15 years) have the option of receiving a two dose HPV
vaccine series at either a six month or one year interval to provide protection from HPV 16 …

[HTML][HTML] Cervical cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing

AC Chrysostomou, DC Stylianou, A Constantinidou… - Viruses, 2018 - mdpi.com
Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

[HTML][HTML] Opportunities and challenges for human papillomavirus vaccination in cancer

R Roden, PL Stern - Nature Reviews Cancer, 2018 - nature.com
The discovery of genotype 16 as the prototype oncogenic human papillomavirus (HPV)
initiated a quarter century of laboratory and epidemiological studies that demonstrated their …

The demand for a COVID-19 vaccine in Ecuador

O Sarasty, CE Carpio, D Hudson, PA Guerrero-Ochoa… - Vaccine, 2020 - Elsevier
Abstract In Latin America, the country of Ecuador was one of the first and most severely
affected by the COVID-19 pandemic. This study aimed to evaluate the demand for a COVID …

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors

C Simoens, PPL Martin‐Hirsch - Cochrane database of …, 2018 - cochranelibrary.com
Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …